Literature DB >> 28074396

Target mediated drug disposition with drug-drug interaction, Part II: competitive and uncompetitive cases.

Gilbert Koch1, William J Jusko2, Johannes Schropp3.   

Abstract

We present competitive and uncompetitive drug-drug interaction (DDI) with target mediated drug disposition (TMDD) equations and investigate their pharmacokinetic DDI properties. For application of TMDD models, quasi-equilibrium (QE) or quasi-steady state (QSS) approximations are necessary to reduce the number of parameters. To realize those approximations of DDI TMDD models, we derive an ordinary differential equation (ODE) representation formulated in free concentration and free receptor variables. This ODE formulation can be straightforward implemented in typical PKPD software without solving any non-linear equation system arising from the QE or QSS approximation of the rapid binding assumptions. This manuscript is the second in a series to introduce and investigate DDI TMDD models and to apply the QE or QSS approximation.

Entities:  

Keywords:  Competitive; Drug–drug interaction; Target-mediated drug disposition; Uncompetitive

Mesh:

Substances:

Year:  2017        PMID: 28074396      PMCID: PMC5470635          DOI: 10.1007/s10928-016-9502-0

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  13 in total

1.  General pharmacokinetic model for drugs exhibiting target-mediated drug disposition.

Authors:  D E Mager; W J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2001-12       Impact factor: 2.745

2.  Affinity, intrinsic activity and drug interactions.

Authors:  E J ARIENS; J M VAN ROSSUM; A M SIMONIS
Journal:  Pharmacol Rev       Date:  1957-06       Impact factor: 25.468

3.  Evaluation of enzyme inhibitors in drug discovery. A guide for medicinal chemists and pharmacologists.

Authors:  Robert A Copeland
Journal:  Methods Biochem Anal       Date:  2005

Review 4.  Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond.

Authors:  Stuart A Lipton
Journal:  Nat Rev Drug Discov       Date:  2006-02       Impact factor: 84.694

5.  Quasi-equilibrium pharmacokinetic model for drugs exhibiting target-mediated drug disposition.

Authors:  Donald E Mager; Wojciech Krzyzanski
Journal:  Pharm Res       Date:  2005-09-22       Impact factor: 4.200

6.  Why is uncompetitive inhibition so rare? A possible explanation, with implications for the design of drugs and pesticides.

Authors:  A Cornish-Bowden
Journal:  FEBS Lett       Date:  1986-07-14       Impact factor: 4.124

Review 7.  Pharmacologic target-mediated drug disposition.

Authors:  G Levy
Journal:  Clin Pharmacol Ther       Date:  1994-09       Impact factor: 6.875

Review 8.  Lithium and the phosphoinositide cycle: an example of uncompetitive inhibition and its pharmacological consequences.

Authors:  S R Nahorski; C I Ragan; R A Challiss
Journal:  Trends Pharmacol Sci       Date:  1991-08       Impact factor: 14.819

9.  Methods of solving rapid binding target-mediated drug disposition model for two drugs competing for the same receptor.

Authors:  Xiaoyu Yan; Yang Chen; Wojciech Krzyzanski
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-08-29       Impact factor: 2.745

10.  Dynamics of target-mediated drug disposition: characteristic profiles and parameter identification.

Authors:  Lambertus A Peletier; Johan Gabrielsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-08-01       Impact factor: 2.745

View more
  5 in total

1.  Target-mediated drug disposition with drug-drug interaction, Part I: single drug case in alternative formulations.

Authors:  Gilbert Koch; William J Jusko; Johannes Schropp
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-01-10       Impact factor: 2.745

2.  Asymptotic analysis of a TMDD model: when a reaction contributes to the destruction of its product.

Authors:  Lida I Michalaki; Dimitris A Goussis
Journal:  J Math Biol       Date:  2018-04-19       Impact factor: 2.259

3.  New Equilibrium Models of Drug-Receptor Interactions Derived from Target-Mediated Drug Disposition.

Authors:  Lambertus A Peletier; Johan Gabrielsson
Journal:  AAPS J       Date:  2018-05-14       Impact factor: 4.009

4.  Population pharmacokinetics and covariate analysis of Sym004, an antibody mixture against the epidermal growth factor receptor, in subjects with metastatic colorectal cancer and other solid tumors.

Authors:  Lene Alifrangis; Rik Schoemaker; Niels J Skartved; Rikke Hald; Clara Montagut; Scott Kopetz; Josep Tabernero; Michael Kragh; Janet R Wade
Journal:  J Pharmacokinet Pharmacodyn       Date:  2019-11-02       Impact factor: 2.745

5.  Target-Mediated Drug Disposition Model for Bispecific Antibodies: Properties, Approximation, and Optimal Dosing Strategy.

Authors:  Johannes Schropp; Antari Khot; Dhaval K Shah; Gilbert Koch
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2019-01-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.